World's Best Scientists 2026 revealed!

D-Index & Metrics

Neuroscience

D-Index
56
Citations
14189
World Ranking
4471
National Ranking
2025

Carl W. Bazil publication distribution in Neuroscience in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Neuroscience in 2026. The highlighted bar marks where Carl W. Bazil sits on this spectrum.

38–47 publications: 18 scientists 48–57 publications: 79 scientists 58–67 publications: 193 scientists 68–77 publications: 323 scientists 78–87 publications: 406 scientists 88–97 publications: 452 scientists 98–107 publications: 539 scientists 108–117 publications: 505 scientists 118–127 publications: 522 scientists 128–137 publications: 469 scientists 138–147 publications: 456 scientists 148–157 publications: 459 scientists 158–167 publications: 397 scientists 168–177 publications: 383 scientists 178–187 publications: 350 scientists 188–197 publications: 302 scientists 198–207 publications: 306 scientists 208–217 publications: 262 scientists 218–227 publications: 242 scientists 228–237 publications: 220 scientists 238–247 publications: 203 scientists 248–257 publications: 174 scientists 258–267 publications: 176 scientists 268–277 publications: 175 scientists 278–287 publications: 125 scientists 288–297 publications: 116 scientists 298–307 publications: 127 scientists 308–317 publications: 128 scientists 318–327 publications: 99 scientists 328–337 publications: 89 scientists 338–347 publications: 78 scientists 348–357 publications: 96 scientists 358–367 publications: 66 scientists 368–377 publications: 59 scientists 378–387 publications: 65 scientists 388–397 publications: 54 scientists 398–407 publications: 48 scientists 408–417 publications: 49 scientists 418–427 publications: 34 scientists 428–437 publications: 31 scientists 438–447 publications: 30 scientists 448–457 publications: 31 scientists 458–467 publications: 36 scientists 468–477 publications: 40 scientists 478–487 publications: 35 scientists 488–497 publications: 30 scientists 498–507 publications: 23 scientists 508–517 publications: 26 scientists 518–527 publications: 20 scientists 528–537 publications: 23 scientists 538–547 publications: 20 scientists 548–557 publications: 20 scientists 558–567 publications: 17 scientists 568–577 publications: 14 scientists 578–587 publications: 20 scientists 588–597 publications: 20 scientists 598–607 publications: 19 scientists 608–617 publications: 18 scientists 618–627 publications: 17 scientists 628–637 publications: 11 scientists 638–647 publications: 11 scientists 648–657 publications: 11 scientists 658–667 publications: 8 scientists 668–677 publications: 7 scientists 678–687 publications: 11 scientists 688–697 publications: 10 scientists 698–707 publications: 4 scientists 708–717 publications: 6 scientists 718–727 publications: 5 scientists 728–737 publications: 5 scientists 738–747 publications: 9 scientists 748–757 publications: 9 scientists 758–767 publications: 3 scientists 768–777 publications: 7 scientists 778–787 publications: 7 scientists 788–797 publications: 6 scientists 798–807 publications: 2 scientists 808–817 publications: 2 scientists 818–827 publications: 7 scientists 828–837 publications: 0 scientists 838–847 publications: 9 scientists 848–857 publications: 3 scientists 858–867 publications: 1 scientists 868–877 publications: 3 scientists 878–886 publications: 6 scientists 887+ publications: 100 scientists
38 publications 887+

This scientist: 175 publications — 53rd percentile

53% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 887 publications or more.

Carl W. Bazil D-index placement in Neuroscience in 2026

The chart shows the D-index (discipline H-index) distribution of Neuroscience scientists ranked by Research.com in 2026. The highlighted bar marks where Carl W. Bazil sits on this spectrum.

30–31 D-Index: 42 scientists 32–33 D-Index: 172 scientists 34–35 D-Index: 296 scientists 36–37 D-Index: 435 scientists 38–39 D-Index: 459 scientists 40–41 D-Index: 456 scientists 42–43 D-Index: 467 scientists 44–45 D-Index: 478 scientists 46–47 D-Index: 512 scientists 48–49 D-Index: 435 scientists 50–51 D-Index: 425 scientists 52–53 D-Index: 418 scientists 54–55 D-Index: 392 scientists 56–57 D-Index: 357 scientists 58–59 D-Index: 334 scientists 60–61 D-Index: 328 scientists 62–63 D-Index: 260 scientists 64–65 D-Index: 278 scientists 66–67 D-Index: 239 scientists 68–69 D-Index: 250 scientists 70–71 D-Index: 210 scientists 72–73 D-Index: 200 scientists 74–75 D-Index: 189 scientists 76–77 D-Index: 170 scientists 78–79 D-Index: 146 scientists 80–81 D-Index: 113 scientists 82–83 D-Index: 126 scientists 84–85 D-Index: 100 scientists 86–87 D-Index: 84 scientists 88–89 D-Index: 99 scientists 90–91 D-Index: 84 scientists 92–93 D-Index: 85 scientists 94–95 D-Index: 72 scientists 96–97 D-Index: 76 scientists 98–99 D-Index: 45 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 43 scientists 104–105 D-Index: 32 scientists 106–107 D-Index: 45 scientists 108–109 D-Index: 50 scientists 110–111 D-Index: 32 scientists 112–113 D-Index: 39 scientists 114–115 D-Index: 32 scientists 116–117 D-Index: 29 scientists 118–119 D-Index: 27 scientists 120–121 D-Index: 19 scientists 122–123 D-Index: 23 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 16 scientists 128–129 D-Index: 24 scientists 130–131 D-Index: 13 scientists 132–133 D-Index: 21 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 14 scientists 138–139 D-Index: 15 scientists 140–141 D-Index: 10 scientists 142–143 D-Index: 10 scientists 144–145 D-Index: 13 scientists 146–147 D-Index: 9 scientists 148–149 D-Index: 8 scientists 150–151 D-Index: 6 scientists 152–153 D-Index: 6 scientists 154–155 D-Index: 7 scientists 156–157 D-Index: 7 scientists 158–159 D-Index: 10 scientists 160–161 D-Index: 4 scientists 162 D-Index: 8 scientists 163+ D-Index: 100 scientists
30 D-Index 163+

This scientist: 56 D-Index — 54th percentile

54% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 163 D-Index or more.

Overview

Carl W. Bazil is affiliated with Columbia University in the United States. Their research spans multiple interconnected fields, with a particular focus on epilepsy and related neurological and psychiatric conditions.

The scientist's recent publications include the following:

  • Sleep and Epilepsy: a Focused Review of Pathophysiology, Clinical Syndromes, Co-morbidities, and Therapy (2021, Neurotherapeutics)
  • All-cause mortality and SUDEP in a surgical epilepsy population (2020, Epilepsy & Behavior)
  • Development and validation of a predictive model of drug-resistant genetic generalized epilepsy (2020, Neurology)
  • Frontotemporal EEG to guide sedation in COVID-19 related acute respiratory distress syndrome (2021, Clinical Neurophysiology)
  • Proceedings of the Sleep and Epilepsy Workshop: Section 1 Decreasing Seizures: Improving Sleep and Seizures, Themes for Future Research (2021, Epiliepsy currents/Epilepsy currents)

Bazil collaborates frequently with several peers in the field. Notable frequent co-authors include:

  • Hooman Kamel
  • New York
  • Dena B. Dubal
  • San Francisco
  • Bernard Chang

Their research has been published predominantly in venues such as:

  • JAMA Neurology
  • Neurology
  • Neurotherapeutics
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Epilepsy & Behavior

Bazil's work covers several subfields within neuroscience and medicine, including:

  • Psychiatry and Mental Health
  • Cognitive Neuroscience
  • Pediatrics, Perinatology and Child Health
  • Cellular and Molecular Neuroscience
  • Economics and Econometrics

The main research topics addressed across their body of work are:

  • Epilepsy Research and Treatment
  • Pharmacological Effects and Toxicity Studies
  • Sleep and Wakefulness Research
  • Neuroscience and Neuropharmacology Research
  • Genomics and Rare Diseases
  • Pharmaceutical Economics and Policy
  • Health Systems, Economic Evaluations, Quality of Life

Best Publications

  • Electrical stimulation of the anterior nucleus of thalamus for treatment of refractory epilepsy

    Robert Fisher;Vicenta Salanova;Thomas Witt;Robert Worth

  • Efficacy and tolerability of the new antiepileptic drugs I: treatment of new onset epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society.

    J. A. French;A. M. Kanner;J. Bautista;B. Abou-Khalil

  • Two‐year seizure reduction in adults with medically intractable partial onset epilepsy treated with responsive neurostimulation: Final results of the RNS System Pivotal trial

    Christianne N. Heck;David King-Stephens;Andrew D. Massey;Dileep R. Nair

  • Distribution of partial seizures during the sleep--wake cycle: differences by seizure onset site.

    Susan T. Herman;T. S. Walczak;C. W. Bazil

  • How long does it take for partial epilepsy to become intractable

    A. T. Berg;J. Langfitt;S. Shinnar;B. G. Vickrey

  • Effects of sleep and sleep stage on epileptic and nonepileptic seizures

    Carl W. Bazil;Thaddeus S. Walczak

  • Predicting long-term seizure outcome after resective epilepsy surgery The Multicenter Study

    Susan S. Spencer;A. T. Berg;B. G. Vickrey;M. R. Sperling

  • Efficacy and tolerability of the new antiepileptic drugs II: Treatment of refractory epilepsy [RETIRED]

    Unknown

  • Comparison and predictors of rash associated with 15 antiepileptic drugs

    H. Arif;R. Buchsbaum;D. Weintraub;S. Koyfman

  • Brain-responsive neurostimulation in patients with medically intractable mesial temporal lobe epilepsy

    Eric B. Geller;Tara L. Skarpaas;Robert E. Gross;Robert R. Goodman

  • Efficacy and Tolerability of the New Antiepileptic Drugs, II: Treatment of Refractory Epilepsy: Report of the TTA and QSS Subcommittees of the American Academy of Neurology and the American Epilepsy Society

    Jacqueline A. French;Andres M. Kanner;Jocelyn Bautista;Bassel W. Abou-Khalil

  • Changes in depression and anxiety after resective surgery for epilepsy

    O. Devinsky;W. B. Barr;B. G. Vickrey;A. T. Berg

  • Initial outcomes in the Multicenter Study of Epilepsy Surgery.

    Susan S. Spencer;A. T. Berg;B. G. Vickrey;M. R. Sperling

  • Effects of antiepileptic drugs on sleep architecture: a pilot study.

    Benjamin Legros;Carl C.W. Bazil

  • Reduction of rapid eye movement sleep by diurnal and nocturnal seizures in temporal lobe epilepsy.

    Carl W. Bazil;Luiz H. M. Castro;Thaddeus S. Walczak

  • Epilepsy and sleep disturbance.

    Carl W. Bazil

  • The multicenter study of epilepsy surgery: Recruitment and selection for surgery

    Anne T. Berg;Barbara G. Vickrey;John T. Langfitt;Michael R. Sperling

  • Brain-responsive neurostimulation in patients with medically intractable seizures arising from eloquent and other neocortical areas.

    Barbara C. Jobst;Ritu Kapur;Gregory L. Barkley;Carl W. Bazil

  • Health‐related quality of life over time since resective epilepsy surgery

    Susan S. Spencer;Anne T. Berg;Barbara G. Vickrey;Michael R. Sperling

  • Patients with intractable epilepsy have low melatonin, which increases following seizures.

    Carl W. Bazil;Douglas Short;David Crispin;Wei Zheng

  • Appendix D: Efficacy and tolerability of the new antiepileptic drugs II: Treatment of refractory epilepsy: Report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society

    J. A. French;A. M. Kanner;J. Bautista;B. Abou-Khalil

Frequent Co-Authors

Michael R. Sperling
Michael R. Sperling Thomas Jefferson University
Anne T. Berg
Anne T. Berg Northwestern University
John T. Langfitt
John T. Langfitt University of Rochester
Susan S. Spencer
Susan S. Spencer Yale University
Shlomo Shinnar
Shlomo Shinnar Albert Einstein College of Medicine
Lawrence J. Hirsch
Lawrence J. Hirsch Yale University
Thaddeus S. Walczak
Thaddeus S. Walczak University of Minnesota
F. Estelle R. Simons
F. Estelle R. Simons University of Manitoba
Richard B. Kim
Richard B. Kim University of Western Ontario
David N. Juurlink
David N. Juurlink University of Toronto

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring neuroscience online gives you access to innovative formats and flexible pathways. For students eager to launch their careers quickly, 2 year accelerated bachelor degrees offer a faster alternative to the traditional four-year path, letting you enter the workforce sooner.

Neuroscience can also open doors to high-earning careers. If salary is an important factor in your decision, consider reviewing degrees that pay well and easiest college majors with high pay to find related fields that maximize your earning potential.

Affordability is a major concern for many students. Fortunately, you can find an online college that accepts fafsa, making it easier to secure financial aid. Exploring these options will help you find a program that fits your career goals, budget, and timeline.

Best Scientists Citing Carl W. Bazil

Trending Scientists